The inhibitory effect of dihydroartemisinin on non-small cells lung cancer
Dihydroartemisinin (DHA) is an artemisinin (ART) derivative used for the treatment of all kinds of malaria, especially for falciparum malaria and dangerous malaria. With the in-depth research, DHA has attracted more attentions in the field of anticancer. We aim to explore the inhibitory effect of DH...
Saved in:
Main Authors: | Yan Li (Author), Guijie Luan (Author), Ping Guo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitory Effect of Dihydroartemisinin on the Proliferation and Migration of Melanoma Cells and Experimental Lung Metastasis From Melanoma in Mice
by: Qi Zhang, et al.
Published: (2021) -
The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer
by: Guo WJ, et al.
Published: (2017) -
Systematic Transcriptome Analysis Reveals the Inhibitory Function of Cinnamaldehyde in Non-Small Cell Lung Cancer
by: Ru Chen, et al.
Published: (2021) -
Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism
by: Zhao Cui, et al.
Published: (2022) -
Inhibitory Effect of Kurarinone on Growth of Human Non-small Cell Lung Cancer: An Experimental Study Both in Vitro and in Vivo Studies
by: Jie Yang, et al.
Published: (2018)